Introduction
Inherited metabolic disease is commonly associated with ocular pathology and in many cases examination of the eye can provide important clues to the diagnosis. All parts of the eye may be involved and a list of the more common ocular manifestations of inborn errors is given in Table 1 .
Since it is not possible to discuss every disorder, a selected few of particular interest will be discussed. Gyrate atrophy with hyperornithinaemia The characteristic fundoscopic features of this condition have been recognized since the end of the last century but it was not until 1973 that associated biochemical abnormalities, hyperornithinaemia and dibasic aminoaciduria were recognized6.
The patients usually present to an ophthalmologist in childhood with loss of night vision and myopia. The earliest ophthalmoscopic finding is small punched-out, yellowish retinal pigment, epithelial and choroidal defects7'8 but by the time the patients present there are usually the characteristic circular and well demarcated areas of chorioretinal degeneration which are most often found in the mid-periphery of the fundus (Figure 1 ). Narrow bands of dense pigmentation may be seen around the margins of the lesions. These areas enlarge, and may progress posteriorly, which is associated with the constriction of visual fields seen in the second decade. In some patients there may be extensive peripapillary atrophy. By the third decade the majority ofthe retina is involved and the untreated patients are blind. At this stage the fundoscopic picture may be similar to choroideremia though the presence of sharply demarcated choroidal and retinal pigment epithelial lesions, with the velvety macular pigmentation in gyrate atrophy enables the two conditions to be differentiated. The retinal vessels are thin and the optic disc remains relatively pink. Posterior subcapsular cataracts develop in most patients around the beginning of the third decade.
The deterioration in acuity progresses at a variable rate. The fields are concentrically reduced and ring scotomata are sometimes seen; the functional defects are well demarcated, correlating closely with the fundal lesions9. The electro-retinogram (ERG) diminishes in amplitude early, before there is gross fundoscopic evidence of disease.
Although these patients have no detectable muscle weakness and normal creatine phosphokinase activity, electromyography and skeletal muscle histology is abnormal. Type II skeletal muscle fibres are small and contain deposits which electron microscopy shows to be non-specific tubular aggregates8"l0. Patients with gyrate atrophy have elevated concentrations of ornithine in the plasma with an overflow dibasic aminoaciduria. The defect is due to reduced activity of ornithine aminotransferase (OAT), which is responsible for the conversion of ornithine to glutamate semialdehyde ( Figure 2) . The deficiency has been demonstrated in a number of tissues including skin fibroblasts. As a result of the enzyme block, the formation of creatine and proline are reduced (Figure 2) .
The enzyme requires pyridoxine as a cofactor and in some patients pharmacological doses ofthe vitamin increase enzyme activity thereby reducing plasma ornithine concentrations". In those patients who do not respond to pyrixodine, other forms of treatment have been tried directed at reducing the high ornithine concentrations, either by a low arginine diet or by promoting urinary excretion of ornithine'2.
These prevented further deterioration of the ERG in some patients only and since the treatment was demanding compliance was poor.
Tada et al.13 realized that patients with hyperornithinaemia for other reasons did not develop gyrate atrophy and he found a patient with gyrate atrophy who did not have hyperornithinaemia but whose plasma proline levels were low. The activity of OAT and the next enzyme in the pathway (pyrroline-5-carboxylic acid reductase) are important for proline synthesis and the activity of the enzymes in retinal tissue is high. Tada Fat malabsorption is present from birth causing steatorrhoea and failure to thrive. Ocular disease starts with night blindness and decreased visual acuity, but the age of onset is very variable. Although early cases show only subtle retinal changes, in advanced cases retinal changes with depigmentation and clumps of hyper-pigmentation giving a 'bone-spicule' appearance on fundoscopy with vessel attentuation and a waxy yellow optic disc are seen. Further investigation shows decreased acuity, field defects including constriction, ring scotomata and a diminished or absent ERG. The earliest neurological sign is diminished tendon reflexes which usually develops in the first decade and will progress to severe ataxic neuropathy.
The biochemical basis is absence of the apolipoprotein (apoB), leading to a failure of formation of low density lipoprotein (LDL), very low density lipoprotein (VLDL) and chylomicrons. The failure of chylomicron formation leads to accumulation of fat in the enterocyte and malabsorption. Since vitamin A, which is fat soluble, is essential for normal retinal function, its deficiency was postulated as the cause for the retinopathy but adequate supplementation with this vitamin alone did not prevent progression of retinal dysfunction in some patients'5. Uptake of vitamin E is reduced and the concentration of this vitamin in plasma which is carried in lipoproteins is undetectably low. Large supplements of vitamin E prevent the progression of both the retinopathy and the neuropathy when given in large doses sufficient to correct the abnormal red cell haemolysis in vitro15 '16. Vitamin E deficiency will develop in any patient with chronic fat malabsorption including cystic fibrosis and chronic obstructive liver disease. Both ocular and neurological complications will develop eventually but can be prevented by treatment with vitamin E.
Zellweger's syndrome and related disorders Zellweger's syndrome (ZS, cerebro-hepato-renal syndrome) is an autosomal recessive disorder characterized by dysmorphic features, including widely open fontanelle, high forehead, broad nasal bridge, high arched palate, abnormalities of the external ear, foot deformities and cryptorchidism17 (Figure 3) . Patients who have severe hypotonia, depressed or Table 2 ). The earliest finding is lens dislocation, which is thought to be due to zonular stretching and degeneration. The condition appears to be progressive so that although only 35% of patients were noted to have lens subluxation by 5 years of age, the figure at 25 years of age was 90%. The dislocation is frequently anterior with pupil block glaucoma occurring more frequently than in other causes of dislocated lenses21 (Figure 4) . The other features of cystathionine-#-synthase deficiency are well known.
The patients are often tall with characteristic skeletal abnormalities.
There is a high incidence of mental retardation. However it is less well appreciated that just as the phenotypic expression varies so does the homocystine excretion. The screening test most widely used is the nitroprusside test but it is not sensitive and it is possible to miss cases.
In some patients the homocystine excretion is persistently low but in others it may be low because they are taking a vitamin supplement containing pyridoxine, the cofactor for the enzyme. Thus all patients with ectopia lentis should be investigated carefully. In addition to a dietary and drug history, methionine loading may even be necessary to demonstrate the homocystinuria. There is a risk of vascular complications with a 30% risk of thromboembolism before 20 years of age and a 60% risk before 40. These episodes seem to affect the cerebrovascular and peripheral circulations21. This makes these patients an anaesthetic risk and adequate hydration should be ensured. Some advocate a small dose of aspirin preoperatively. There is now considerable evidence that heterozygotes, although free of ocular disease, may suffer similar vascular complication22'23.
Conclusion
Patients with inborn errors of metabolism may have characteristic ocular changes which are in some cases diagnostic, but for others detailed investigation may be necessary to establish the diagnosis. This is essential for the appropriate treatment to prevent progressive ocular disease and to enable the family to be counselled accurately about the genetic risk and the consideration of prenatal diagnosis.
